News

BioM's articles and press releases about the Bavarian biotechnology sector


Personalized cell therapeutics against cancer

ap­ceth starts second round of fund­ing in the Lead­ing-Edge Cluster m4 – Per­son­al­ized Medi­cine

Chinese biotech expert in Martinsried

11 cluster part­ners got ad­vise on busi­ness de­vel­op­ment in China

Berlin event: Companion Diagnostic – and IP

This BIOCOM Event of­fers a unique op­por­tun­ity to gain in­sight into the con­ver­ging strategies of pharma and dia­gnostics com­pan­ies.

m⁴ Seminar - new dates

The Mu­nich sem­in­ar series about per­son­al­ized medi­cine is con­tin­ued on Feb 21st and Mar 12th, 2013

New EU-Project in integrative omics-data-analysis: STATegra

Bio­max (Martin­sried) and Lud­wig-Max­imili­ans University (LMU) are part­ners.

Roche to invest 240 million Swiss francs in diagnostics production in Germany

The new Pen­zberg pro­duc­tion fa­cil­ity will help meet rising de­mand for dia­gnost­ic products and adds to Roche Group’s largest European…

Genomatix and CeGAT are among the 3 finalists of the Clarity competition

Full gen­ome se­quen­cing helps with the dia­gnos­is of dif­fi­cult cases

Freising-based XL-protein and Wacker annouce long-term cooperation

Pro­long­a­tion of the plasma half life of bio­lo­gics

Genesis Life Science and Healthcare Networking Conference

40 % dis­count for the BioM Net­zwerk for the con­fer­ence and part­ner­ing event in Lon­don

New agents for cancer immunotherapy: 4SC m⁴ receives grant

TLR7/TLR9 ag­on­ists will be de­veloped in co­oper­a­tion with the LMU uni­ver­sity hos­pit­al

Newsletter

Subscribe

Archive


05.06.2024

Friedrich-Alexander-Universität Erlangen-Nürnberg

Unter den be­sten 15 Prozent aller Universitäten der Welt

05.06.2024

Fraunhofer ISC,Fraunhofer Translationszentrum für Regenerative Therapien TLZ-RT

Haut­mod­elle als Al­tern­at­ive zu Ti­erver­suchen

04.06.2024

BITKOM Bundesverband Informationswirtschaft, Telekommunikation und neue Medien e.V.

Star­tups in Deutsch­land: Zwis­chen Hof­fen und Ban­gen

03.06.2024

vfa bio Biotechnologie im Verband Forschender Arzneimittelhersteller e.V.

Phar­mas­trategie wirkt: Normal­ität bei Her­steller­ab­sch­lag wieder herges­tellt

03.06.2024

vfa bio Biotechnologie im Verband Forschender Arzneimittelhersteller e.V.

Pharma fängt Beschäf­ti­gungs­ver­luste auf


Publish press release

 To the login


Gabriele Klingner
Gabriele Klingner

Communications & Marketing Lead


Christiane Proll
Christiane Proll

PR & Social Media Manager